Abstract:Background: Diabetic kidney disease (DKD) is one of the most serious microvascular complications of diabetes mellitus (DM) and the leading cause of chronic kidney disease (CKD) worldwide. Since obesity and type 2 DM (T2DM) are considered as inflammatory conditions, thus reducing their accompanied systemic inflammation may lessen their complications. Sestrin 2 belongs to a group of stress induced proteins which are produced in response to oxidative stress, inflammation and DNA damage. Betatrophin; a hormone that stimulates the growth, proliferation and mass expansion of pancreatic beta-cells and improves glucose tolerance. The objective of the study was to evaluate levels of serum Sestrin 2 and betatrophin in patients with different stages of diabetic nephropathy (DN)) and compare results with healthy control. Methods: This cross sectional study was carried out on 60 patients above 18 years old, recruited from Tanta University hospitals out patients clinics and 20 apparently healthy individuals of matched sex and age as a control group. Participants were divided into two groups: group I: 20 normal subjects as control group and group II: 60 patients with type 2 DM,. further subdivided in to three equal groups: group 1IIA(20 patients) with normo-albuminuria (ACR < 30 mg/g), group IIB (20 patients) with micro albuminuria (ACR = 30 to 300 mg/g) and group IIC (20 patients) with macro albuminuria (ACR > 300 mg/g). They were subjected to detailed history taking, careful clinical examination and laboratory investigations including blood urea, serum creatinine, estimated glomerular filtration rate (eGFR), urinary albumin creatinine ratio, and specific laboratory tests for Sestrin 2 and Betatrophin by using ELISA technique. Results: Serum Sestrin 2 significantly decreased, while serum betatrophin level significantly increased in macroalbuminuric group compared to control and other 2 diabetic groups (P value < 0.05). The cut off value of serum sestrin 2 was 0.98 ng/ml with sensitivity 99%, specificity 66% while the cut off value of serum betatrophin was > 98.25 ng/ml with sensitivity 98%, specificity 82%. Serum betatrophin positively correlated with age, fasting, 2 h postprandial, BMI, triglyceride, total cholesterol, serum creatinine, blood urea, UACR, and negatively correlated with eGFR and serum albumin. Serum Sestrin 2 positively correlated with serum albumin. BMI, serum urea, UACR and serum albumin. Serum betatrophin are found to be risk factors or predictors for diabetic nephropathy. Conclusions: Patients with DN, particularly the macroalbuminuria group, had a significant increase in betatrophin levels and a significant decrease in serum Sestrin 2 level. The function of Sestrin 2 is compromised in DN, and restoring it can reverse a series of molecular alterations with subsequent improvement of the renal functions, albuminuria and structural damage.

Circulating Betatrophin Levels Are Increased in Patients with Type 2 Diabetes and Associated with Insulin Resistance

Serum betatrophin level increased in subjects with metabolic syndrome: a case-control study

Association between transthyretin concentrations and gestational diabetes mellitus in Chinese women

Betatrophin and Insulin Resistance

Serum betatrophin level increased in subjects with nonalcoholic fatty liver disease

Betatrophin Provides a New Insight into Diabetes Treatment and Lipid Metabolism (Review).

[Elevated serum levels of betatrophin in patients with polycystic ovary syndrome and the influential factors]

Association of high circulating testosterone with increased glycaemic variability in type 2 diabetes: A cross-sectional study in China

Evaluation of serum levels of sestrin 2 and betatrophin in type 2 diabetic patients with diabetic nephropathy

Circulating C1q complement/TNF-related protein (CTRP) 1, CTRP9, CTRP12 and CTRP13 concentrations in Type 2 diabetes mellitus: In vivo regulation by glucose

Influence of circulating nesfatin-1, GSH and SOD on insulin secretion in the development of T2DM

Serum Leptin, Resistin, and Adiponectin Levels in Obese and Non-Obese Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Population-Based Study.

[Role of Insulin Resistance and Β Cell Function in the Development of Newly Diagnosed Type 2 Diabetes].

Circulating Proteome and Progression of Type 2 Diabetes

Decreased circulating BMP-9 levels in patients with Type 2 diabetes is a signature of insulin resistance

Association of circulating B-type natriuretic peptide with osteoporosis in a Chinese type 2 diabetic population

Analysis of the Variation Levels of APN, Insulin, Sensitive C-Reactive Protein and Leptin in the Serum of Patients with Type 2 Diabetes Mellitus

Decreased serum levels of 25-OH vitamin D and vitamin K in patients with type 2 diabetes mellitus

Serum Vitamin D and Its Upregulated Protein, Thioredoxin Interacting Protein, Are Associated With Beta-Cell Dysfunction in Adult Patients With Type 1 and Type 2 Diabetes

Plasma Transthyretin Levels and Risk of Type 2 Diabetes Mellitus and Impaired Glucose Regulation in a Chinese Population

Serum betatrophin levels and fatty acid profile in gestational diabetes mellitus: Correlation with insulin resistance